Impact BioMedical, INC. Net Income (Loss) Attributable to Noncontrolling Interest
Impact BioMedical, INC. (IBO) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-07
- Impact BioMedical, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$1.00K.
- Impact BioMedical, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was $3.00K.
- Impact BioMedical, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$10.00K.
- Impact BioMedical, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$5.00K.
- Impact BioMedical, INC. net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$32.00K.
- Impact BioMedical, INC. net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$62.00K.
- Impact BioMedical, INC. net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$71.00K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.00K 10-Q · filed 2026-08-07 | $2.00K 10-Q · filed 2026-08-07 | -$8.00K derived: sum of 3 quarters · filed 2026-08-07 | -$13.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $3.00K 10-Q · filed 2026-05-12 | -$7.00K derived: sum of 2 quarters · filed 2026-05-12 | -$12.00K derived: sum of 3 quarters · filed 2026-05-12 | -$18.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$15.00K derived: sum of 2 quarters · filed 2026-03-11 | -$21.00K derived: sum of 3 quarters · filed 2026-08-07 | -$32.00K 10-K · filed 2026-03-11 |
| 2025-09-30 | -$5.00K 10-Q · filed 2025-11-07 | -$11.00K derived: sum of 2 quarters · filed 2026-08-07 | -$22.00K 10-Q · filed 2025-11-07 | -$47.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$6.00K 10-Q · filed 2026-08-07 | -$17.00K 10-Q · filed 2026-08-07 | -$42.00K derived: sum of 3 quarters · filed 2026-08-07 | -$48.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$11.00K 10-Q · filed 2026-05-12 | -$36.00K derived: sum of 2 quarters · filed 2026-05-12 | -$42.00K derived: sum of 3 quarters · filed 2026-05-12 | -$37.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$31.00K derived: sum of 2 quarters · filed 2026-03-11 | -$26.00K derived: sum of 3 quarters · filed 2026-03-11 | -$62.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | -$6.00K 10-Q · filed 2025-11-07 | -$1.00K derived: sum of 2 quarters · filed 2025-11-07 | -$37.00K 10-Q · filed 2025-11-07 | -$63.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $5.00K 10-Q · filed 2025-08-14 | -$31.00K 10-Q · filed 2025-08-14 | -$57.00K derived: sum of 3 quarters · filed 2025-08-14 | -$72.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$36.00K 10-Q · filed 2025-05-14 | -$62.00K derived: sum of 2 quarters · filed 2025-05-14 | -$77.00K derived: sum of 3 quarters · filed 2025-05-14 | -$96.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$41.00K derived: sum of 2 quarters · filed 2025-03-28 | -$60.00K derived: sum of 3 quarters · filed 2025-03-28 | -$71.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | -$15.00K 10-Q · filed 2024-11-12 | -$34.00K derived: sum of 2 quarters · filed 2024-11-12 | -$45.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$19.00K 10-Q · filed 2024-08-13 | -$30.00K 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |